Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life
Dipak Kotecha(University Hospitals Birmingham NHS Foundation Trust), Jonathan J Deeks, Samir Mehta(University of Birmingham), Karina V Bunting, A. John Camm(St George's, University of London), Kazem Rahimi(University of Oxford), Mary Stanbury(West Midlands Police), Victoria Y. Strauss(University of Oxford), John Townend(NIHR Surgical Reconstruction and Microbiology Research Centre), Gregory Y.H. Lip(University of Liverpool), Paulus Kirchhof(University of Birmingham), Richard P. Steeds(University Hospitals Birmingham NHS Foundation Trust), Melanie Calvert(National Institute for Health and Care Research), Simrat Gill(University Hospitals Birmingham NHS Foundation Trust), Sandra Haynes(West Midlands Police), J. C. H. Jones(West Midlands Police), Michael Griffith(University Hospitals Birmingham NHS Foundation Trust)
Cited by 229
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|EP Europace|2016|6.5k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|European Heart Journal|2016|6.4k
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
|The Lancet|2015|3.7k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k